Momenta Pharmaceuticals to Webcast Presentation at the 2016 Wells Fargo Healthcare Conference
August 31 2016 - 4:45PM
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, today announced that it will provide a corporate
overview, including an update on the status of the Company’s
necuparanib program, at the 2016 Wells Fargo Healthcare Conference
in Boston, MA. The presentation is scheduled to begin on Wednesday,
September 7th at 1:45 p.m. ET.
The audio webcast of the presentation will be
available live on the “Investors” section of the company’s website
located at www.momentapharma.com. A replay of the presentation will
be posted on the Momenta website approximately one hour after the
event.
About MomentaMomenta
Pharmaceuticals is a biotechnology company specializing in the
detailed structural analysis of complex drugs and is headquartered
in Cambridge, MA. Momenta is applying its technology to
the development of generic versions of complex drugs, biosimilar
and potentially interchangeable biologics, and to the discovery and
development of novel therapeutics for oncology and autoimmune
indications.
To receive additional information about Momenta,
please visit the website at www.momentapharma.com, which does
not form a part of this press release.
Our logo, trademarks, and service marks are the
property of Momenta Pharmaceuticals, Inc. All other trade names,
trademarks, or service marks are property of their respective
owners.
Contact:
Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Apr 2023 to Apr 2024